- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens introduces Sonoline upgrades
Siemens Medical Systems’ ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the unit’s applications to include surgical and intensive care uses. The company unveiled five new transducers for its
Siemens Medical Systems ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the units applications to include surgical and intensive care uses. The company unveiled five new transducers for its Sonoline Sienna 2.0 unit for surgery and intensive care environments. The transducers will allow physicians to use Sonoline Sienna for traditional open surgeries, ultrasound-guided biopsies and aspiration procedures, and laparoscopies.
The four interventional transducers7.5L50, 7.5L50-Q, Lb5-2 Biopsy Linear Array, and LAP 8-4are smaller and lighter and carry higher resolution than other transducers, and were developed for such indications as vascular imaging. Issaquah, WA-based Siemens developed its fifth transducer, C8-5, for neonatal intensive care.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
